Displaying 97 - 108 items out of 159 results
ILCN article
New Approaches Improve Mesothelioma Outcomes
… be replaced by “mesothelioma” for all uses, pathology researcher says. … New Approaches Improve Mesothelioma Outcomes …
ILCN article
Pragmatic Approach to Trial Design Born from Lung-MAP Substudy
… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …
ILCN article
Session to Explore Unmet Patient Needs, Opportunities in Lung Cancer
… the Go2 Foundation’s Brittney Nichols, MPH—will present research on global challenges in lung cancer care during the …
ILCN article
Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration
… to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center …
ILCN article
Inflammation’s Dark Symphony: Lung Cancer and Depression in Concert
… Dr. Barbara Andersen’s research has shown depression severity is associated with …
ILCN article
Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer
… Forde, who is director of the Thoracic Oncology Clinical Research Program and associate professor of Oncology at Johns …
ILCN article
Gender Disparity in Lung Cancer
… for gender-sensitive approaches in healthcare policy, research, and clinical practice. … Gender Disparity in Lung …
ILCN article
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
… of care and limited resources to review applications, researchers say they support the agency’s decision not to …
ILCN article
World Conference Conversations: Inside WCLC 2025
… to reflect on the latest advances and cutting-edge research in thoracic oncology. Noemi Reguart, MD, PhD In early …
ILCN article
Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care
… On Monday, August 8, four researchers will share data showing the benefits of …
ILCN article
ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC
… Spigel, MD, Chief Scientific Officer at the Sarah Cannon Research Institute in Nashville, Tennessee, as he began his …











